Fan Chenxi, Sun Xin, Wang Xin, Yu Hongsong
Department of Immunology, Special Key Laboratory of Ocular Diseases of Guizhou Province, Zunyi Medical University, Zunyi, Guizhou, China.
Special Key Laboratory of Gene Detection and Therapy of Guizhou Province, School of Basic Medical Sciences, Zunyi Medical University, Zunyi, Guizhou, China.
Front Pharmacol. 2023 Jul 11;14:1163830. doi: 10.3389/fphar.2023.1163830. eCollection 2023.
Lindl. belongs to the genus of the orchid family and is a valuable herbal medicinal material. The information in this paper has been collected from the scientific literature databases including PubMed, Google Scholar, Web of Science, SciFinder, China National Knowledge Infrastructure, published books, Ph.D., and M.S. dissertations systematically in recent 20 years. " Lindl.," "chemical composition," "pharmacological activities," and "diseases" were used as search terms to screen the literature. The collected chemical compositions are classified and summarized according to their different chemical structures, and the clinical disease treatment effects of Lindl. are classified and summarized based on their pharmacological activities and different experimental disease models. Recent studies have revealed that Lindl. contains chemical components such as alkaloids, bibenzyls, sesquiterpenes, phenanthrenes, and polysaccharides, and that its pharmacological activities are closely related to the chemical components, with pharmacological activities such as anti-tumor, anti-aging, immune enhancement, hypoglycemic, and anti-cataract. Currently, researchers are conducting extensive and detailed studies on Lindl. and research experiments on its chemical constituents in the treatment of various clinical diseases. Therefore, the purpose of this paper is to review the chemical composition of Lindl. and its experimental studies in the treatment of diseases and to provide a scientific reference for the future application of Lindl. in the treatment of diseases.
[植物名称(林氏[某种植物],原文未明确具体中文名)]属于兰科植物属,是一种珍贵的中药材。本文中的信息是从包括PubMed、谷歌学术、科学网、SciFinder、中国知网等科学文献数据库,以及已出版的书籍、博士论文和硕士论文中系统收集而来,时间跨度为近20年。以“[植物名称(林氏[某种植物])]”“化学成分”“药理活性”和“疾病”作为检索词来筛选文献。收集到的化学成分根据其不同的化学结构进行分类和总结,[植物名称(林氏[某种植物])]的临床疾病治疗效果则根据其药理活性和不同的实验疾病模型进行分类和总结。最近的研究表明,[植物名称(林氏[某种植物])]含有生物碱、联苄、倍半萜、菲类和多糖等化学成分,其药理活性与这些化学成分密切相关,具有抗肿瘤、抗衰老、增强免疫、降血糖和抗白内障等药理活性。目前,研究人员正在对[植物名称(林氏[某种植物])]进行广泛而详细的研究,并对其化学成分在治疗各种临床疾病方面进行研究实验。因此,本文的目的是综述[植物名称(林氏[某种植物])]的化学成分及其在疾病治疗方面的实验研究,为[植物名称(林氏[某种植物])]未来在疾病治疗中的应用提供科学参考。